AKT1 and hepatocellular carcinoma: Moreover, (AChE) could inactivate the mitogen-activated protein kinase and phosphatidyl inositol-3-phosphate kinase/protein kinase B pathways in HCC cells, thereby increasing the activation of glycogen synthase kinase 3β, leading to β-catenin degradation and cyclin D1 suppression35.